nodes	percent_of_prediction	percent_of_DWPC	metapath
Dicyclomine—CHRM3—muscle of abdomen—ovarian cancer	0.0132	0.551	CbGeAlD
Dicyclomine—Pruritus—Chlorambucil—ovarian cancer	0.00227	0.00232	CcSEcCtD
Dicyclomine—Urticaria—Topotecan—ovarian cancer	0.00227	0.00232	CcSEcCtD
Dicyclomine—Abdominal pain—Topotecan—ovarian cancer	0.00225	0.00231	CcSEcCtD
Dicyclomine—Urticaria—Melphalan—ovarian cancer	0.00222	0.00227	CcSEcCtD
Dicyclomine—Thrombophlebitis—Epirubicin—ovarian cancer	0.00221	0.00226	CcSEcCtD
Dicyclomine—Paraesthesia—Vinorelbine—ovarian cancer	0.00219	0.00224	CcSEcCtD
Dicyclomine—Dyspnoea—Vinorelbine—ovarian cancer	0.00218	0.00223	CcSEcCtD
Dicyclomine—Eye disorder—Paclitaxel—ovarian cancer	0.00216	0.00221	CcSEcCtD
Dicyclomine—Cardiac disorder—Paclitaxel—ovarian cancer	0.00214	0.0022	CcSEcCtD
Dicyclomine—Decreased appetite—Vinorelbine—ovarian cancer	0.00212	0.00217	CcSEcCtD
Dicyclomine—Gastrointestinal disorder—Vinorelbine—ovarian cancer	0.00211	0.00216	CcSEcCtD
Dicyclomine—Fatigue—Vinorelbine—ovarian cancer	0.0021	0.00216	CcSEcCtD
Dicyclomine—Hypersensitivity—Topotecan—ovarian cancer	0.0021	0.00215	CcSEcCtD
Dicyclomine—Pain—Vinorelbine—ovarian cancer	0.00209	0.00214	CcSEcCtD
Dicyclomine—Constipation—Vinorelbine—ovarian cancer	0.00209	0.00214	CcSEcCtD
Dicyclomine—Immune system disorder—Paclitaxel—ovarian cancer	0.00209	0.00214	CcSEcCtD
Dicyclomine—Mediastinal disorder—Paclitaxel—ovarian cancer	0.00208	0.00213	CcSEcCtD
Dicyclomine—Hypersensitivity—Melphalan—ovarian cancer	0.00206	0.00211	CcSEcCtD
Dicyclomine—Asthenia—Topotecan—ovarian cancer	0.00205	0.0021	CcSEcCtD
Dicyclomine—Thrombophlebitis—Doxorubicin—ovarian cancer	0.00204	0.00209	CcSEcCtD
Dicyclomine—Vomiting—Chlorambucil—ovarian cancer	0.00204	0.00209	CcSEcCtD
Dicyclomine—Mental disorder—Paclitaxel—ovarian cancer	0.00202	0.00207	CcSEcCtD
Dicyclomine—Pruritus—Topotecan—ovarian cancer	0.00202	0.00207	CcSEcCtD
Dicyclomine—Erythema—Paclitaxel—ovarian cancer	0.00201	0.00206	CcSEcCtD
Dicyclomine—Feeling abnormal—Vinorelbine—ovarian cancer	0.00201	0.00206	CcSEcCtD
Dicyclomine—Asthenia—Melphalan—ovarian cancer	0.002	0.00205	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Vinorelbine—ovarian cancer	0.00199	0.00204	CcSEcCtD
Dicyclomine—Pruritus—Melphalan—ovarian cancer	0.00198	0.00202	CcSEcCtD
Dicyclomine—Tension—Paclitaxel—ovarian cancer	0.00197	0.00202	CcSEcCtD
Dicyclomine—Nervousness—Paclitaxel—ovarian cancer	0.00195	0.002	CcSEcCtD
Dicyclomine—Hypoaesthesia—Docetaxel—ovarian cancer	0.00195	0.002	CcSEcCtD
Dicyclomine—Lethargy—Epirubicin—ovarian cancer	0.00195	0.002	CcSEcCtD
Dicyclomine—Urticaria—Vinorelbine—ovarian cancer	0.00194	0.00199	CcSEcCtD
Dicyclomine—Abdominal pain—Vinorelbine—ovarian cancer	0.00193	0.00198	CcSEcCtD
Dicyclomine—Diplopia—Epirubicin—ovarian cancer	0.00191	0.00196	CcSEcCtD
Dicyclomine—Nausea—Chlorambucil—ovarian cancer	0.0019	0.00195	CcSEcCtD
Dicyclomine—Vision blurred—Paclitaxel—ovarian cancer	0.00189	0.00194	CcSEcCtD
Dicyclomine—Dizziness—Topotecan—ovarian cancer	0.00189	0.00193	CcSEcCtD
Dicyclomine—Affect lability—Epirubicin—ovarian cancer	0.00188	0.00192	CcSEcCtD
Dicyclomine—Ill-defined disorder—Paclitaxel—ovarian cancer	0.00187	0.00191	CcSEcCtD
Dicyclomine—Agitation—Paclitaxel—ovarian cancer	0.00185	0.00189	CcSEcCtD
Dicyclomine—Face oedema—Epirubicin—ovarian cancer	0.00184	0.00189	CcSEcCtD
Dicyclomine—Angioedema—Paclitaxel—ovarian cancer	0.00184	0.00188	CcSEcCtD
Dicyclomine—Eye disorder—Docetaxel—ovarian cancer	0.00183	0.00187	CcSEcCtD
Dicyclomine—Cardiac disorder—Docetaxel—ovarian cancer	0.00182	0.00186	CcSEcCtD
Dicyclomine—Vomiting—Topotecan—ovarian cancer	0.00181	0.00186	CcSEcCtD
Dicyclomine—Malaise—Paclitaxel—ovarian cancer	0.00181	0.00186	CcSEcCtD
Dicyclomine—Mood swings—Epirubicin—ovarian cancer	0.00181	0.00185	CcSEcCtD
Dicyclomine—Syncope—Paclitaxel—ovarian cancer	0.0018	0.00185	CcSEcCtD
Dicyclomine—Lethargy—Doxorubicin—ovarian cancer	0.0018	0.00185	CcSEcCtD
Dicyclomine—Rash—Topotecan—ovarian cancer	0.0018	0.00184	CcSEcCtD
Dicyclomine—Hypersensitivity—Vinorelbine—ovarian cancer	0.0018	0.00184	CcSEcCtD
Dicyclomine—Dermatitis—Topotecan—ovarian cancer	0.0018	0.00184	CcSEcCtD
Dicyclomine—Headache—Topotecan—ovarian cancer	0.00179	0.00183	CcSEcCtD
Dicyclomine—Palpitations—Paclitaxel—ovarian cancer	0.00178	0.00182	CcSEcCtD
Dicyclomine—Vomiting—Melphalan—ovarian cancer	0.00178	0.00182	CcSEcCtD
Dicyclomine—Immune system disorder—Docetaxel—ovarian cancer	0.00177	0.00181	CcSEcCtD
Dicyclomine—Loss of consciousness—Paclitaxel—ovarian cancer	0.00177	0.00181	CcSEcCtD
Dicyclomine—Diplopia—Doxorubicin—ovarian cancer	0.00177	0.00181	CcSEcCtD
Dicyclomine—Mediastinal disorder—Docetaxel—ovarian cancer	0.00176	0.00181	CcSEcCtD
Dicyclomine—Rash—Melphalan—ovarian cancer	0.00176	0.0018	CcSEcCtD
Dicyclomine—Dermatitis—Melphalan—ovarian cancer	0.00176	0.0018	CcSEcCtD
Dicyclomine—Asthenia—Vinorelbine—ovarian cancer	0.00175	0.00179	CcSEcCtD
Dicyclomine—Affect lability—Doxorubicin—ovarian cancer	0.00174	0.00178	CcSEcCtD
Dicyclomine—Hypertension—Paclitaxel—ovarian cancer	0.00174	0.00178	CcSEcCtD
Dicyclomine—Pruritus—Vinorelbine—ovarian cancer	0.00173	0.00177	CcSEcCtD
Dicyclomine—Breast disorder—Epirubicin—ovarian cancer	0.00172	0.00177	CcSEcCtD
Dicyclomine—Mental disorder—Docetaxel—ovarian cancer	0.00172	0.00176	CcSEcCtD
Dicyclomine—Face oedema—Doxorubicin—ovarian cancer	0.00171	0.00175	CcSEcCtD
Dicyclomine—Erythema—Docetaxel—ovarian cancer	0.0017	0.00175	CcSEcCtD
Dicyclomine—Nausea—Topotecan—ovarian cancer	0.00169	0.00174	CcSEcCtD
Dicyclomine—Discomfort—Paclitaxel—ovarian cancer	0.00169	0.00173	CcSEcCtD
Dicyclomine—Muscular weakness—Epirubicin—ovarian cancer	0.00168	0.00172	CcSEcCtD
Dicyclomine—Dry mouth—Paclitaxel—ovarian cancer	0.00167	0.00172	CcSEcCtD
Dicyclomine—Mood swings—Doxorubicin—ovarian cancer	0.00167	0.00171	CcSEcCtD
Dicyclomine—Abdominal distension—Epirubicin—ovarian cancer	0.00166	0.0017	CcSEcCtD
Dicyclomine—Nausea—Melphalan—ovarian cancer	0.00166	0.0017	CcSEcCtD
Dicyclomine—Confusional state—Paclitaxel—ovarian cancer	0.00165	0.0017	CcSEcCtD
Dicyclomine—Anaphylactic shock—Paclitaxel—ovarian cancer	0.00164	0.00168	CcSEcCtD
Dicyclomine—Oedema—Paclitaxel—ovarian cancer	0.00164	0.00168	CcSEcCtD
Dicyclomine—Shock—Paclitaxel—ovarian cancer	0.00161	0.00165	CcSEcCtD
Dicyclomine—Dizziness—Vinorelbine—ovarian cancer	0.00161	0.00165	CcSEcCtD
Dicyclomine—Nervous system disorder—Paclitaxel—ovarian cancer	0.00161	0.00165	CcSEcCtD
Dicyclomine—Tachycardia—Paclitaxel—ovarian cancer	0.0016	0.00164	CcSEcCtD
Dicyclomine—Breast disorder—Doxorubicin—ovarian cancer	0.0016	0.00164	CcSEcCtD
Dicyclomine—Anorexia—Paclitaxel—ovarian cancer	0.00156	0.0016	CcSEcCtD
Dicyclomine—Muscular weakness—Doxorubicin—ovarian cancer	0.00156	0.0016	CcSEcCtD
Dicyclomine—Vomiting—Vinorelbine—ovarian cancer	0.00155	0.00159	CcSEcCtD
Dicyclomine—Rash—Vinorelbine—ovarian cancer	0.00154	0.00158	CcSEcCtD
Dicyclomine—Dermatitis—Vinorelbine—ovarian cancer	0.00154	0.00157	CcSEcCtD
Dicyclomine—Abdominal distension—Doxorubicin—ovarian cancer	0.00154	0.00157	CcSEcCtD
Dicyclomine—Headache—Vinorelbine—ovarian cancer	0.00153	0.00157	CcSEcCtD
Dicyclomine—Syncope—Docetaxel—ovarian cancer	0.00153	0.00157	CcSEcCtD
Dicyclomine—Palpitations—Docetaxel—ovarian cancer	0.00151	0.00154	CcSEcCtD
Dicyclomine—Loss of consciousness—Docetaxel—ovarian cancer	0.0015	0.00153	CcSEcCtD
Dicyclomine—Insomnia—Paclitaxel—ovarian cancer	0.00148	0.00152	CcSEcCtD
Dicyclomine—Paraesthesia—Paclitaxel—ovarian cancer	0.00147	0.00151	CcSEcCtD
Dicyclomine—Hypertension—Docetaxel—ovarian cancer	0.00147	0.00151	CcSEcCtD
Dicyclomine—Drowsiness—Epirubicin—ovarian cancer	0.00147	0.00151	CcSEcCtD
Dicyclomine—Dyspnoea—Paclitaxel—ovarian cancer	0.00146	0.0015	CcSEcCtD
Dicyclomine—Somnolence—Paclitaxel—ovarian cancer	0.00146	0.00149	CcSEcCtD
Dicyclomine—Nausea—Vinorelbine—ovarian cancer	0.00145	0.00148	CcSEcCtD
Dicyclomine—Dyspepsia—Paclitaxel—ovarian cancer	0.00144	0.00148	CcSEcCtD
Dicyclomine—Decreased appetite—Paclitaxel—ovarian cancer	0.00143	0.00146	CcSEcCtD
Dicyclomine—Dry mouth—Docetaxel—ovarian cancer	0.00142	0.00145	CcSEcCtD
Dicyclomine—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.00142	0.00145	CcSEcCtD
Dicyclomine—Fatigue—Paclitaxel—ovarian cancer	0.00141	0.00145	CcSEcCtD
Dicyclomine—Pain—Paclitaxel—ovarian cancer	0.0014	0.00144	CcSEcCtD
Dicyclomine—Constipation—Paclitaxel—ovarian cancer	0.0014	0.00144	CcSEcCtD
Dicyclomine—Confusional state—Docetaxel—ovarian cancer	0.0014	0.00144	CcSEcCtD
Dicyclomine—Anaphylactic shock—Docetaxel—ovarian cancer	0.00139	0.00143	CcSEcCtD
Dicyclomine—Oedema—Docetaxel—ovarian cancer	0.00139	0.00143	CcSEcCtD
Dicyclomine—Shock—Docetaxel—ovarian cancer	0.00137	0.0014	CcSEcCtD
Dicyclomine—Nervous system disorder—Docetaxel—ovarian cancer	0.00136	0.0014	CcSEcCtD
Dicyclomine—Drowsiness—Doxorubicin—ovarian cancer	0.00136	0.00139	CcSEcCtD
Dicyclomine—Tachycardia—Docetaxel—ovarian cancer	0.00136	0.00139	CcSEcCtD
Dicyclomine—Feeling abnormal—Paclitaxel—ovarian cancer	0.00135	0.00139	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.00134	0.00137	CcSEcCtD
Dicyclomine—Anorexia—Docetaxel—ovarian cancer	0.00133	0.00136	CcSEcCtD
Dicyclomine—Hypoaesthesia—Epirubicin—ovarian cancer	0.00131	0.00135	CcSEcCtD
Dicyclomine—Urticaria—Paclitaxel—ovarian cancer	0.0013	0.00134	CcSEcCtD
Dicyclomine—CHRM1—female reproductive system—ovarian cancer	0.0013	0.0544	CbGeAlD
Dicyclomine—Abdominal pain—Paclitaxel—ovarian cancer	0.0013	0.00133	CcSEcCtD
Dicyclomine—Insomnia—Docetaxel—ovarian cancer	0.00126	0.00129	CcSEcCtD
Dicyclomine—Paraesthesia—Docetaxel—ovarian cancer	0.00125	0.00128	CcSEcCtD
Dicyclomine—Dyspnoea—Docetaxel—ovarian cancer	0.00124	0.00127	CcSEcCtD
Dicyclomine—Somnolence—Docetaxel—ovarian cancer	0.00124	0.00127	CcSEcCtD
Dicyclomine—Eye disorder—Epirubicin—ovarian cancer	0.00123	0.00126	CcSEcCtD
Dicyclomine—Cardiac disorder—Epirubicin—ovarian cancer	0.00123	0.00126	CcSEcCtD
Dicyclomine—Dyspepsia—Docetaxel—ovarian cancer	0.00122	0.00125	CcSEcCtD
Dicyclomine—Hypoaesthesia—Doxorubicin—ovarian cancer	0.00122	0.00125	CcSEcCtD
Dicyclomine—Decreased appetite—Docetaxel—ovarian cancer	0.00121	0.00124	CcSEcCtD
Dicyclomine—Hypersensitivity—Paclitaxel—ovarian cancer	0.00121	0.00124	CcSEcCtD
Dicyclomine—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.0012	0.00123	CcSEcCtD
Dicyclomine—Fatigue—Docetaxel—ovarian cancer	0.0012	0.00123	CcSEcCtD
Dicyclomine—Immune system disorder—Epirubicin—ovarian cancer	0.00119	0.00122	CcSEcCtD
Dicyclomine—Mediastinal disorder—Epirubicin—ovarian cancer	0.00119	0.00122	CcSEcCtD
Dicyclomine—Pain—Docetaxel—ovarian cancer	0.00119	0.00122	CcSEcCtD
Dicyclomine—Constipation—Docetaxel—ovarian cancer	0.00119	0.00122	CcSEcCtD
Dicyclomine—Asthenia—Paclitaxel—ovarian cancer	0.00118	0.00121	CcSEcCtD
Dicyclomine—CYP1A1—epithelium—ovarian cancer	0.00118	0.0491	CbGeAlD
Dicyclomine—CHRM3—female reproductive system—ovarian cancer	0.00117	0.0487	CbGeAlD
Dicyclomine—CYP1A1—uterine cervix—ovarian cancer	0.00117	0.0487	CbGeAlD
Dicyclomine—Pruritus—Paclitaxel—ovarian cancer	0.00116	0.00119	CcSEcCtD
Dicyclomine—Mental disorder—Epirubicin—ovarian cancer	0.00116	0.00119	CcSEcCtD
Dicyclomine—Erythema—Epirubicin—ovarian cancer	0.00115	0.00118	CcSEcCtD
Dicyclomine—Feeling abnormal—Docetaxel—ovarian cancer	0.00115	0.00117	CcSEcCtD
Dicyclomine—Eye disorder—Doxorubicin—ovarian cancer	0.00114	0.00117	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Docetaxel—ovarian cancer	0.00114	0.00117	CcSEcCtD
Dicyclomine—Cardiac disorder—Doxorubicin—ovarian cancer	0.00113	0.00116	CcSEcCtD
Dicyclomine—Tension—Epirubicin—ovarian cancer	0.00113	0.00116	CcSEcCtD
Dicyclomine—Nervousness—Epirubicin—ovarian cancer	0.00112	0.00114	CcSEcCtD
Dicyclomine—Immune system disorder—Doxorubicin—ovarian cancer	0.0011	0.00113	CcSEcCtD
Dicyclomine—Mediastinal disorder—Doxorubicin—ovarian cancer	0.0011	0.00113	CcSEcCtD
Dicyclomine—Abdominal pain—Docetaxel—ovarian cancer	0.0011	0.00113	CcSEcCtD
Dicyclomine—Dizziness—Paclitaxel—ovarian cancer	0.00109	0.00111	CcSEcCtD
Dicyclomine—Vision blurred—Epirubicin—ovarian cancer	0.00108	0.00111	CcSEcCtD
Dicyclomine—Mental disorder—Doxorubicin—ovarian cancer	0.00107	0.0011	CcSEcCtD
Dicyclomine—Ill-defined disorder—Epirubicin—ovarian cancer	0.00107	0.00109	CcSEcCtD
Dicyclomine—Erythema—Doxorubicin—ovarian cancer	0.00106	0.00109	CcSEcCtD
Dicyclomine—CHRM3—female gonad—ovarian cancer	0.00106	0.0443	CbGeAlD
Dicyclomine—Agitation—Epirubicin—ovarian cancer	0.00106	0.00108	CcSEcCtD
Dicyclomine—Tension—Doxorubicin—ovarian cancer	0.00104	0.00107	CcSEcCtD
Dicyclomine—Vomiting—Paclitaxel—ovarian cancer	0.00104	0.00107	CcSEcCtD
Dicyclomine—Malaise—Epirubicin—ovarian cancer	0.00104	0.00106	CcSEcCtD
Dicyclomine—Rash—Paclitaxel—ovarian cancer	0.00103	0.00106	CcSEcCtD
Dicyclomine—Dermatitis—Paclitaxel—ovarian cancer	0.00103	0.00106	CcSEcCtD
Dicyclomine—Nervousness—Doxorubicin—ovarian cancer	0.00103	0.00106	CcSEcCtD
Dicyclomine—Syncope—Epirubicin—ovarian cancer	0.00103	0.00106	CcSEcCtD
Dicyclomine—Headache—Paclitaxel—ovarian cancer	0.00103	0.00105	CcSEcCtD
Dicyclomine—Hypersensitivity—Docetaxel—ovarian cancer	0.00102	0.00105	CcSEcCtD
Dicyclomine—Palpitations—Epirubicin—ovarian cancer	0.00102	0.00104	CcSEcCtD
Dicyclomine—Loss of consciousness—Epirubicin—ovarian cancer	0.00101	0.00104	CcSEcCtD
Dicyclomine—Vision blurred—Doxorubicin—ovarian cancer	0.001	0.00103	CcSEcCtD
Dicyclomine—Asthenia—Docetaxel—ovarian cancer	0.000998	0.00102	CcSEcCtD
Dicyclomine—Hypertension—Epirubicin—ovarian cancer	0.000992	0.00102	CcSEcCtD
Dicyclomine—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000987	0.00101	CcSEcCtD
Dicyclomine—Pruritus—Docetaxel—ovarian cancer	0.000984	0.00101	CcSEcCtD
Dicyclomine—Agitation—Doxorubicin—ovarian cancer	0.000977	0.001	CcSEcCtD
Dicyclomine—Nausea—Paclitaxel—ovarian cancer	0.000975	0.000999	CcSEcCtD
Dicyclomine—CYP1A1—uterus—ovarian cancer	0.000972	0.0406	CbGeAlD
Dicyclomine—Discomfort—Epirubicin—ovarian cancer	0.000967	0.000991	CcSEcCtD
Dicyclomine—Malaise—Doxorubicin—ovarian cancer	0.000959	0.000983	CcSEcCtD
Dicyclomine—Dry mouth—Epirubicin—ovarian cancer	0.000957	0.000981	CcSEcCtD
Dicyclomine—Syncope—Doxorubicin—ovarian cancer	0.000954	0.000977	CcSEcCtD
Dicyclomine—Confusional state—Epirubicin—ovarian cancer	0.000946	0.000969	CcSEcCtD
Dicyclomine—CHRM3—testis—ovarian cancer	0.000941	0.0393	CbGeAlD
Dicyclomine—Palpitations—Doxorubicin—ovarian cancer	0.00094	0.000963	CcSEcCtD
Dicyclomine—Anaphylactic shock—Epirubicin—ovarian cancer	0.000938	0.000961	CcSEcCtD
Dicyclomine—Oedema—Epirubicin—ovarian cancer	0.000938	0.000961	CcSEcCtD
Dicyclomine—Loss of consciousness—Doxorubicin—ovarian cancer	0.000935	0.000958	CcSEcCtD
Dicyclomine—Shock—Epirubicin—ovarian cancer	0.000923	0.000946	CcSEcCtD
Dicyclomine—Nervous system disorder—Epirubicin—ovarian cancer	0.00092	0.000943	CcSEcCtD
Dicyclomine—Dizziness—Docetaxel—ovarian cancer	0.00092	0.000942	CcSEcCtD
Dicyclomine—Hypertension—Doxorubicin—ovarian cancer	0.000918	0.000941	CcSEcCtD
Dicyclomine—Tachycardia—Epirubicin—ovarian cancer	0.000916	0.000938	CcSEcCtD
Dicyclomine—Discomfort—Doxorubicin—ovarian cancer	0.000895	0.000917	CcSEcCtD
Dicyclomine—Anorexia—Epirubicin—ovarian cancer	0.000894	0.000916	CcSEcCtD
Dicyclomine—Dry mouth—Doxorubicin—ovarian cancer	0.000886	0.000907	CcSEcCtD
Dicyclomine—Vomiting—Docetaxel—ovarian cancer	0.000884	0.000906	CcSEcCtD
Dicyclomine—Rash—Docetaxel—ovarian cancer	0.000877	0.000899	CcSEcCtD
Dicyclomine—Dermatitis—Docetaxel—ovarian cancer	0.000876	0.000898	CcSEcCtD
Dicyclomine—Confusional state—Doxorubicin—ovarian cancer	0.000875	0.000897	CcSEcCtD
Dicyclomine—CYP1A1—female reproductive system—ovarian cancer	0.000873	0.0365	CbGeAlD
Dicyclomine—Headache—Docetaxel—ovarian cancer	0.000871	0.000893	CcSEcCtD
Dicyclomine—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000868	0.000889	CcSEcCtD
Dicyclomine—Oedema—Doxorubicin—ovarian cancer	0.000868	0.000889	CcSEcCtD
Dicyclomine—Shock—Doxorubicin—ovarian cancer	0.000854	0.000875	CcSEcCtD
Dicyclomine—Nervous system disorder—Doxorubicin—ovarian cancer	0.000851	0.000872	CcSEcCtD
Dicyclomine—Insomnia—Epirubicin—ovarian cancer	0.000849	0.000869	CcSEcCtD
Dicyclomine—Tachycardia—Doxorubicin—ovarian cancer	0.000847	0.000868	CcSEcCtD
Dicyclomine—Paraesthesia—Epirubicin—ovarian cancer	0.000842	0.000863	CcSEcCtD
Dicyclomine—Dyspnoea—Epirubicin—ovarian cancer	0.000836	0.000857	CcSEcCtD
Dicyclomine—Somnolence—Epirubicin—ovarian cancer	0.000834	0.000854	CcSEcCtD
Dicyclomine—Anorexia—Doxorubicin—ovarian cancer	0.000827	0.000848	CcSEcCtD
Dicyclomine—Nausea—Docetaxel—ovarian cancer	0.000826	0.000846	CcSEcCtD
Dicyclomine—Dyspepsia—Epirubicin—ovarian cancer	0.000826	0.000846	CcSEcCtD
Dicyclomine—Decreased appetite—Epirubicin—ovarian cancer	0.000816	0.000836	CcSEcCtD
Dicyclomine—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.00081	0.00083	CcSEcCtD
Dicyclomine—Fatigue—Epirubicin—ovarian cancer	0.000809	0.000829	CcSEcCtD
Dicyclomine—Pain—Epirubicin—ovarian cancer	0.000802	0.000822	CcSEcCtD
Dicyclomine—Constipation—Epirubicin—ovarian cancer	0.000802	0.000822	CcSEcCtD
Dicyclomine—CYP1A1—female gonad—ovarian cancer	0.000795	0.0332	CbGeAlD
Dicyclomine—CYP1A1—vagina—ovarian cancer	0.00079	0.033	CbGeAlD
Dicyclomine—Insomnia—Doxorubicin—ovarian cancer	0.000785	0.000804	CcSEcCtD
Dicyclomine—Paraesthesia—Doxorubicin—ovarian cancer	0.000779	0.000799	CcSEcCtD
Dicyclomine—Dyspnoea—Doxorubicin—ovarian cancer	0.000774	0.000793	CcSEcCtD
Dicyclomine—Feeling abnormal—Epirubicin—ovarian cancer	0.000773	0.000792	CcSEcCtD
Dicyclomine—Somnolence—Doxorubicin—ovarian cancer	0.000772	0.000791	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000767	0.000786	CcSEcCtD
Dicyclomine—Dyspepsia—Doxorubicin—ovarian cancer	0.000764	0.000783	CcSEcCtD
Dicyclomine—Decreased appetite—Doxorubicin—ovarian cancer	0.000755	0.000773	CcSEcCtD
Dicyclomine—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000749	0.000768	CcSEcCtD
Dicyclomine—Fatigue—Doxorubicin—ovarian cancer	0.000748	0.000767	CcSEcCtD
Dicyclomine—Urticaria—Epirubicin—ovarian cancer	0.000745	0.000764	CcSEcCtD
Dicyclomine—Pain—Doxorubicin—ovarian cancer	0.000742	0.000761	CcSEcCtD
Dicyclomine—Constipation—Doxorubicin—ovarian cancer	0.000742	0.000761	CcSEcCtD
Dicyclomine—Abdominal pain—Epirubicin—ovarian cancer	0.000742	0.00076	CcSEcCtD
Dicyclomine—Feeling abnormal—Doxorubicin—ovarian cancer	0.000715	0.000733	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.00071	0.000727	CcSEcCtD
Dicyclomine—Hypersensitivity—Epirubicin—ovarian cancer	0.000691	0.000708	CcSEcCtD
Dicyclomine—Urticaria—Doxorubicin—ovarian cancer	0.00069	0.000707	CcSEcCtD
Dicyclomine—Abdominal pain—Doxorubicin—ovarian cancer	0.000686	0.000703	CcSEcCtD
Dicyclomine—Asthenia—Epirubicin—ovarian cancer	0.000673	0.00069	CcSEcCtD
Dicyclomine—Pruritus—Epirubicin—ovarian cancer	0.000664	0.00068	CcSEcCtD
Dicyclomine—Hypersensitivity—Doxorubicin—ovarian cancer	0.00064	0.000655	CcSEcCtD
Dicyclomine—Asthenia—Doxorubicin—ovarian cancer	0.000623	0.000638	CcSEcCtD
Dicyclomine—Dizziness—Epirubicin—ovarian cancer	0.00062	0.000636	CcSEcCtD
Dicyclomine—Pruritus—Doxorubicin—ovarian cancer	0.000614	0.000629	CcSEcCtD
Dicyclomine—Vomiting—Epirubicin—ovarian cancer	0.000596	0.000611	CcSEcCtD
Dicyclomine—Rash—Epirubicin—ovarian cancer	0.000592	0.000606	CcSEcCtD
Dicyclomine—Dermatitis—Epirubicin—ovarian cancer	0.000591	0.000605	CcSEcCtD
Dicyclomine—Headache—Epirubicin—ovarian cancer	0.000588	0.000602	CcSEcCtD
Dicyclomine—Dizziness—Doxorubicin—ovarian cancer	0.000574	0.000588	CcSEcCtD
Dicyclomine—Nausea—Epirubicin—ovarian cancer	0.000557	0.000571	CcSEcCtD
Dicyclomine—Vomiting—Doxorubicin—ovarian cancer	0.000552	0.000565	CcSEcCtD
Dicyclomine—Rash—Doxorubicin—ovarian cancer	0.000547	0.000561	CcSEcCtD
Dicyclomine—Dermatitis—Doxorubicin—ovarian cancer	0.000547	0.00056	CcSEcCtD
Dicyclomine—Headache—Doxorubicin—ovarian cancer	0.000544	0.000557	CcSEcCtD
Dicyclomine—Nausea—Doxorubicin—ovarian cancer	0.000516	0.000528	CcSEcCtD
Dicyclomine—CYP1A1—lymph node—ovarian cancer	0.000511	0.0213	CbGeAlD
